Penn State Health Holy Spirit Medical Center is a 307-bed non-profit Catholic community hospital located in Camp Hill, Pennsylvania, a suburb of Harrisburg, Pennsylvania, and serves as the primary facility for its related health system.

There are 311 beds in Holy Spirit Hospital.

During the past decade, Holy Spirit Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Spirit Hospital" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Amgen" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Cook Research Incorporated" with 1 trials sponsored and "Cordis Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Spirit Hospital" #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Geisinger Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Holy Spirit Hospital" are "Coronary Artery Disease" (6 trials), "Coronary Disease" (4 trials), "Coronary Artery Stenosis" (3 trials), "Coronary Stenosis" (3 trials) and "Coronary Restenosis" (2 trials). Many other conditions were trialed in "Holy Spirit Hospital" in a lesser frequency.

Most popular intervention types in "Holy Spirit Hospital" are "Device" (9 trials), "Drug" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE" (3 trials), "Absorb BVS" (2 trials), "(BMS/DES)" (1 trials), "DAPT" (1 trials) and "Evolocumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holy Spirit Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Holy Spirit Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Holy Spirit Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Spirit Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Holy Spirit Hospital has several departments that took part in Clinical trials: "Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center" - 79 trials, "Berks Cardiologists, Ltd." - 16 trials, "Holy Spirit Cardiovascular Institute" - 5 trials, "Andrew and Patel Associates" - 2 trials, "Andrews and Patel Associates" - 2 trials, "Penn State Heart and Vascular Institute" - 2 trials